Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel

Israel implemented use of 7- and 13-valent pneumococcal vaccine in 2009 and 2010, respectively. We describe results of prospective, population-based, nationwide active surveillance of Streptococcus pneumoniae serotype 12F (Sp12F) invasive pneumococcal disease (IPD) dynamics in the 7 years after vacc...

Descripció completa

Dades bibliogràfiques

Autors principals:	Assaf Rokney, Shalom Ben-Shimol, Zinaida Korenman, Nurith Porat, Zeev Gorodnitzky, Noga Givon-Lavi, Merav Ron, Vered Agmon, Ron Dagan, Lea Valinsky
Format:	Artigo
Idioma:	Inglês
Publicat:	Centers for Disease Control and Prevention 2018-03-01
Col·lecció:	Emerging Infectious Diseases
Matèries:	Streptocococcus pneumoniae infections 12F polysaccharides Streptocococcus pneumoniae 7-valent pneumococcal vaccine 13-valent pneumococcal vaccine emerging infectious diseases Israel
Accés en línia:	https://wwwnc.cdc.gov/eid/article/24/3/17-0769_article
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!